ACAD
ACADIA Pharmaceuticals (ACAD) Earnings
Review ACADIA Pharmaceuticals (ACAD) earnings with server-rendered company data, supporting context and links to related investor research.
- Annual EPS
- 2.3
- Trailing EPS
- 2.22
- Annual revenue
- $1.07B
- Trailing revenue
- $1.14B
- Next earnings date
- 2026-08-04
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
ACADIA Pharmaceuticals (ACAD) Earnings research
The ACAD earnings page organizes the available earnings-per-share and revenue context for ACADIA Pharmaceuticals. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.